omeprazole has been researched along with rifamycins in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbara, L; Holton, J; Menegatti, M; Vaira, D | 1 |
Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN | 1 |
Bjarnason, I; Dolak, W; Grimaldi, M; Lanas, A; Matzneller, P; Renzulli, C; Scarpignato, C; Zeitlinger, M | 1 |
Donday, MG; Gisbert, JP; McNicholl, AG; Ramas, M | 1 |
3 trial(s) available for omeprazole and rifamycins
Article | Year |
---|---|
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin | 2011 |
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Female; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Intestine, Small; Logistic Models; Male; Omeprazole; Proton Pump Inhibitors; Rifamycins; Rifaximin; Severity of Illness Index; Ulcer | 2017 |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Young Adult | 2017 |
1 other study(ies) available for omeprazole and rifamycins
Article | Year |
---|---|
The susceptibility of Helicobacter pylori to the rifamycin, rifaximin.
Topics: Ampicillin; Drug Interactions; Drug Therapy, Combination; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Rifamycins; Rifaximin | 1995 |